J. Ironside

J. Ironside, 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Neuropathology of Neurodegenerative Diseases: Human prion diseases

J. Ironside, M. Head, D. Ritchie, 2000 .

Neuropathology of Human Prion Diseases.

J. Ironside, D. Ritchie, 2017, Progress in molecular biology and translational science.

Variably Protease-Sensitive Prionopathy, a Unique Prion Variant with Inefficient Transmission Properties

J. Ironside, J. Manson, D. Ritchie, 2014, Emerging infectious diseases.

Quantitative Study of Spongiform Change in Putamen of 24 Cases of Creutzfeldt‐Jakob Disease

J. Ironside, N. Kopp, A. Bencsik, 2004, Journal of neuropathology and experimental neurology.

Distinct Stability States of Disease-Associated Human Prion Protein Identiﬁed by Conformation-Dependent Immunoassay (cid:1)

J. Ironside, M. Head, A. Gröner, 2010 .

Oral infection by the bovine spongiform encephalopathy prion.

J. Ironside, R. Will, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of prion-protein conversion: a therapeutic tool?

J. Ironside, M. Head, 2000, Trends in microbiology.

Validation of diagnostic criteria for variant Creutzfeldt–Jakob disease

J. Ironside, R. Will, M. Zeidler, 2010, Annals of Neurology.

Gerstmann-Sträussler-Scheinker disease with atypical presentation

J. Ironside, J. O'Riordan, S. Keuss, 2017, BMJ Case Reports.

Phenotypic Variability of Gerstmann-Straussler-Scheinker Disease is Associated with Prion Protein Heterogeneity

D. Dickson, B. Ghetti, S. Kish, 1998, Journal of neuropathology and experimental neurology.

Investigation of Variant Creutzfeldt-Jakob Disease Implicated Organ or Tissue Transplantation in the United Kingdom

A. Molesworth, J. Ironside, G. Galea, 2014, Transplantation.

Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion.

B. Caughey, J. Ironside, A. Green, 2012, The Journal of general virology.

Transplantation of ocular tissue from a donor with sporadic Creutzfeldt–Jakob disease

J. Ironside, M. Head, R. Buckley, 2006, Clinical & experimental ophthalmology.

Abnormal prion protein in the retina of the most commonly occurring subtype of sporadic Creutzfeldt-Jakob disease

J. Ironside, M. Head, D. Ritchie, 2005, British Journal of Ophthalmology.

Variably protease-sensitive prionopathy in the UK: a retrospective review 1991-2008.

J. Langeveld, J. Ironside, M. Head, 2013, Brain : a journal of neurology.

A quantitative study of the pathological changes in the cerebellum in 15 cases of variant Creutzfeldt–Jakob disease (vCJD)

P. Lantos, N. Cairns, J. Ironside, 2009, Neuropathology and applied neurobiology.

Clinical, neuropathological and immunohistochemical features of sporadic and variant forms of Creutzfeldt-Jakob disease in the squirrel monkey (Saimiri sciureus).

P. Brown, J. Ironside, T. Kreil, 2007, The Journal of general virology.

The first case of variant Creutzfeldt-Jakob disease in the Netherlands

C. V. van Duijn, A. Rozemuller, P. Sánchez-Juan, 2007, Journal of Neurology.

Does the neuropathology of human patients with variant Creutzfeldt–Jakob disease reflect haematogenous spread of the disease?

P. Lantos, N. Cairns, J. Ironside, 2003, Neuroscience Letters.

Prion diseases: update on Creutzfeldt‐Jakob disease

J. Ironside, 1996, Neuropathology and applied neurobiology.

Prion protein accumulation in the spinal cords of patients with sporadic and growth hormone associated Creutzfeldt-Jakob disease

J. Bell, J. Ironside, I. A. Goodbrand, 1995, Neuroscience Letters.

No evidence of asymptomatic variant CJD infection in immunodeficiency patients treated with UK‐sourced immunoglobulin

A. Molesworth, J. Ironside, M. Bishop, 2016, Vox sanguinis.

Diagnosis of Creutzfeldt-Jakob disease

A. Green, J. Ironside, R. Will, 1999, BMJ.

Variant Creutzfeldt-Jakob disease.

J. Ironside, R. Will, 2004, Folia neuropathologica.

Edinburgh Research Explorer Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP

R. Katzenschlager, E. Hametner, J. Ironside, 2013 .

Retention of corneal epithelial cells following Goldmann tonometry: implications for CJD risk

P. Aspinall, K. Kurian, J. Ironside, 2003, The British journal of ophthalmology.

Tissue Handling in Suspected Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases)

W. Schlote, P. Lantos, J. Hauw, 1995, Brain pathology.

Pathological and biochemical investigation of a woman diagnosed with genetic Creutzfeldt–Jakob disease shortly after parturition

É. Keller, J. Ironside, M. Head, 2015, Neuropathology and applied neurobiology.

Preclinical variant CJD after blood transfusion in a PRNP codon 129 heterozygous patient

Mark Head, James W. Ironside, J. Ironside, 2004 .

Presentation of a case of variant CJD in general dental practice

J. Ironside, J. Greene, A. Smith, 2004, British Dental Journal.

The spatial patterns of prion protein deposits in cases of variant Creutzfeldt-Jakob disease

P. Lantos, N. Cairns, J. Ironside, 2002, Acta Neuropathologica.

Laminar distribution of the pathological changes in the cerebral cortex in variant Creutzfeldt-Jakob disease (vCJD).

P. Lantos, N. Cairns, J. Ironside, 2002, Folia neuropathologica.

Sporadic Creutzfeldt-Jakob disease presenting as progressive nonfluent aphasia with speech apraxia.

J. Snowden, J. Thompson, A. Richardson, 2013, Alzheimer disease and associated disorders.

Asymptomatic vCJD infection detected at autopsy in a UK haemophilic patient

J. Ironside, M. Head, H. Ward, 2010 .

Stereotaxic brain biopsy in AIDS patients: does it contribute to patient management?

R. Brettle, J. Bell, I. Whittle, 1994, British journal of neurosurgery.

The identification of cells containing JC papovavirus DNA in progressive multifocal leukoencephalopathy by combined in situ hybridization and immunocytochemistry

J. Ironside, F. Lewis, Fraser Lewis, 1989, The Journal of pathology.

Redox metals and oxidative abnormalities in human prion diseases

Hyoung-Gon Lee, B. Ghetti, H. Budka, 2005, Acta Neuropathologica.

In situ hybridization in neuropathology

M. Cuzner, J. Ironside, M. Woodroofe, 1994, Neuropathology and applied neurobiology.

Impact of radiotherapy parameters on outcome for patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study.

Roger E. Taylor, D. Ellison, J. Ironside, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Edinburgh Research Explorer Cerebellar amyloid-beta plaques: How frequent are they, and do they influence 18F-Florbetaben SUVR?

J. Seibyl, B. Ghetti, O. Sabri, 2016 .

Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies

T. Iwaki, K. Doh-ura, J. Ironside, 2002, Acta Neuropathologica.

family associated with anovel144basepair insertion oftheprion protein gene

R. Lathe, M. Dempster, J. Ironside, 2011 .

Ubiquitin immunocytochemistry in human spongiform encephalopathies

J. Bell, J. Ironside, L. McCardle, 1993, Neuropathology and applied neurobiology.

How to tackle a possible Creutzfeldt-Jakob disease necropsy.

J. Bell, J. Ironside, 1993, Journal of Clinical Pathology.

In situ hybridization analysis of PrP mRNA in human CNS tissues

J. Bell, J. Ironside, N. McLennan, 2001, Neuropathology and applied neurobiology.

Third ventricular chordoid glioma: clinicopathological study of two cases with evidence for a poor clinical outcome despite low grade histological features

J. Bell, K. Kurian, J. Ironside, 2005, Neuropathology and applied neurobiology.

Cerebral Amyloid Angiopathy–Related Hemorrhage Interaction of APOE ε2 With Putative Clinical Risk Factors

S. Love, I. Bone, J. Ironside, 1999 .

Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors.

S. Love, I. Bone, J. Ironside, 1999, Stroke.

Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy

J. Collinge, A. Hill, J. Ironside, 1997, The Lancet.

Association Between Interleukin-1A Polymorphism and Cerebral Amyloid Angiopathy–Related Hemorrhage

D. Graham, D. Mann, S. Love, 2003, Stroke.

Morphologic and immunophenotypic characterization of primary brain lymphomas using paraffin‐embedded tissue

J. Ironside, J. Murphy, C. O'brien, 1989, Histopathology.

Primary intracerebral lymphoma: a clinicopathological analysis of 14 patients presenting over a 10-year period in Sheffield.

J. Ironside, W. Timperley, M. Dorreen, 1988, The Quarterly journal of medicine.

Creutzfeldt-Jakob disease.

P. Liberski, J. Ironside, B. Sikorska, 2012, Advances in experimental medicine and biology.

[A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].

J. Ironside, R. Will, S. V. van Duinen, 1996, Nederlands tijdschrift voor geneeskunde.

Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic

J. Linehan, S. Brandner, M. Simmons, 2013 .

Paraganglioma of the cauda equina: A histological, ultrastructural and immunocytochemical study of two cases with a review of the literature

J. Royds, J. Ironside, W. Timperley, 1985, The Journal of pathology.

Human prion disease

J. Ironside, M. Head, 2020, Definitions.

Sacrificing the superior petrosal vein during microvascular decompression. Is it safe? Learning the hard way. Case report and review of literature

J. Ironside, G. Anichini, M. Kamel, 2016, Surgical neurology international.

A young man with rapidly progressive multifocal disease affecting the white matter

J. Ironside, D. Hilton‐Jones, D. Simpson, 2007, Practical Neurology.

The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype

F. Baas, W. V. van Gool, J. Ironside, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Pathology of Tumours of the Central Nervous System.

J. Ironside, 2001 .

A new variant of Creutzfeldt-Jakob disease: neuropathological and clinical features.

J. Bell, J. Ironside, R. Will, 1996, Cold Spring Harbor symposia on quantitative biology.

Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma.

A. Gregor, I. Whittle, S. Wharton, 2002, Prostaglandins, leukotrienes, and essential fatty acids.

A Neuropsychological-Neuropathological Case Study of Variant Creutzfeldt-Jakob Disease.

N. Kapur, J. Ironside, A. Turner, 2001, Neurocase.

Progressive paraparesis, lymphocytic meningitis, and stroke in a 37-year-old man.

C. Warlow, J. Bamford, J. Ironside, 1994, Journal of neurology, neurosurgery, and psychiatry.

Best Practice No 172

J. Ironside, J. W. Ironside, 2003, Journal of clinical pathology.

Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.

Roger E. Taylor, D. Tait, D. Ellison, 2002, International journal of radiation oncology, biology, physics.

Familial prion disease with a novel serine to isoleucine mutation at codon 132 of prion protein gene (PRNP)

V. Singh, J. Ironside, M. Bishop, 2009, Neuropathology and applied neurobiology.

Macrophage and microglial cell immunoreactivity for PrPc in a random post‐mortem population

M. Esiri, J. Ironside, J. Carter, 2002, Neuropathology and applied neurobiology.

HISTOLOGY OF NEUROBLASTOMA INVOLVING BONE MARROW

J. Ironside, C. Shiach, E. Robinson, 1989, British journal of haematology.

Paraganglioma of the cauda equina.

J. Ironside, 1988, Journal of neurology, neurosurgery, and psychiatry.

Prion protein accumulation and neuroprotection in hypoxic brain damage.

J. Bell, A. McNeill, J. Ironside, 2004, The American journal of pathology.

Stromal cells in cerebellar haemangioblastomas: an immunocytochemical study

T. Stephenson, J. Royds, J. Ironside, 1988, Histopathology.

Cetuximab is effective, but more toxic than reported in the Bonner trial.

J. Ironside, E. Junor, H. Lord, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Further characterisation of the prion protein molecular types detectable in the NIBSC Creutzfeldt-Jakob disease brain reference materials.

J. Ironside, M. Head, H. Yull, 2009, Biologicals : journal of the International Association of Biological Standardization.

Sporadic Creutzfeldt-Jakob disease: further twists and turns in a convoluted protein.

J. Ironside, M. Head, 2006, Brain : a journal of neurology.

Workshop 4: Human Prion Diseases

S. DeArmond, J. Ironside, 1994 .

Cytogenetic studies in 50 meningiomas.

J. Ironside, E. Maltby, R. Battersby, 1988, Cancer genetics and cytogenetics.

Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?

J. Ironside, G. Di Minno, L. Gürtler, 2017, Annals of Hematology.

Glutathione S-transferases and cytochrome P450 detoxifying enzyme distribution in human cerebral glioma

J. Ironside, R. Grant, 2005, Journal of Neuro-Oncology.

Demonstration of Epstein-Barr virus in primary central nervous system lymphomas.

L. Young, J. Ironside, J. Murphy, 1991, Human pathology.

Encephalopathy in a 45-year-old woman: presented at the Advanced Clinical Neurology Course, Edinburgh 2010

J. Ironside, C. Derry, C. Allen, 2012, Practical Neurology.

Microsurgical excision of a pontomedullary epidermoid cyst with prepontine extension: case report.

I. Whittle, J. Ironside, G. Malcolm, 1996, Neurosurgery.

Identification of 5‐HT3 recognition sites in human brain tissue using [3H]zacopride

B. Costall, R. Naylor, N. Barnes, 1988, The Journal of pharmacy and pharmacology.

Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in high grade glioma (HGG)- BR05.

P. Lantos, N. Bleehen, F. Senanayake, 1998 .

Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.

Richard G Grundy, Conor Mallucci, Sophie A Wilne, 2007, The Lancet. Oncology.

Relapsed intracranial ependymoma in children in the UK: patterns of relapse, survival and therapeutic outcome.

C. R. Pinkerton, D. Ellison, T. Jaspan, 2009, European journal of cancer.

The spatial pattern of the vacuolation (‘spongiform change’) in the cerebral cortex in variant Creutzfeldt‐Jakob disease (vCJD)

P. Lantos, N. Cairns, J. Ironside, 2002 .

Ultrastructural analysis of the florid plaque in variant Creutzfeldt-Jakob disease.

P. Liberski, J. Ironside, L. McCardle, 2000, Folia neuropathologica.

Human prion diseases.

J. Ironside, 1996, Journal of neural transmission. Supplementum.

Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice

J. Ironside, G. Di Minno, L. Gürtler, 2013, Haematologica.

Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.

J. Ironside, G. Di Minno, C. Perno, 2013, Seminars in thrombosis and hemostasis.

Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders☆

J. Ironside, G. Di Minno, C. Perno, 2015, Blood Reviews.

Brain banking for neurological disorders

James W Ironside, Rustam Al-Shahi Salman, R. Salman, 2013, The Lancet Neurology.

Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains

J. Attems, C. Troakes, Colin Smith, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium

Isidro Ferrer, Richard Reynolds, Peter Falkai, 2008, Acta Neuropathologica.

Network Analysis of Arachidonic Acid Pathophysiology in Human Phagocytes and Primary Brain Tumors a

A. Gregor, I. Whittle, J. Ironside, 1997, Annals of the New York Academy of Sciences.

Relative Abundance of apoE and Aβ1-42 Associated with Abnormal Prion Protein Differs between Creutzfeldt-Jakob Disease Subtypes.

Roger A. Moore, J. Ironside, S. Priola, 2016, Journal of proteome research.

Distinct Stability States of Disease-Associated Human Prion Protein Identified by Conformation-Dependent Immunoassay

J. Ironside, M. Head, A. Gröner, 2010, Journal of Virology.

Advances in the development of a screening test for variant Creutzfeldt-Jakob disease.

M. Turner, J. Ironside, I. Macgregor, 2008, Expert opinion on medical diagnostics.

Squamous cell carcinoma arising in a subcutaneous dermoid cyst.

J. Ironside, G. Stephenson, 1991, Postgraduate medical journal.

Textbook of neuropathology. 2nd ed. R. L. Davis and D. M. Robertson (Eds). Williams & Wilkins, London, 1991. No. of pages: 1155. Price: £110·00. ISBN: 0 683 02344 6

J. Ironside, 1991 .

Pathogen Safety of Long-Term Treatments for Bleeding Disorders: (Un)Predictable Risks and Evolving Threats

J. Ironside, G. Di Minno, A. Tiede, 2013, Seminars in Thrombosis & Hemostasis.

Squamous cell carcinoma of the eyelid and the acquired immunodeficiency syndrome.

J. Ironside, B. Dhillon, H. Maclean, 1996, American journal of ophthalmology.

Superficial epithelioid schwannoma presenting as a subcutaneous upper eyelid mass.

J. Ironside, Z. Butt, James W. Ironside, 1994, The British journal of ophthalmology.

Increasing incidence of CNS primary lymphoma in south-east Scotland

A. Gregor, I. Whittle, J. Ironside, 1991, The Lancet.

Whipple's disease with cerebral involvement.

J. Ironside, P. Hamal, D. Robson, 1990, Postgraduate medical journal.

Epithelial downgrowth as a complication of toxic anterior segment syndrome.

J. Ironside, F. Imrie, E. J. Wallace, 2007, Journal of cataract and refractive surgery.

Metachronous lymphoma of the breast and conjunctiva.

J. Ironside, H. Maclean, M. Wright, 1996, The British journal of ophthalmology.

Cutaneous malignant melanoma metastatic to the choroid: A clinicopathological case report

J. Ironside, R. Bell, B. Fleck, 1995, Eye.

Russell & Rubinstein's Pathology of Tumors of the Nervous System (6th edition)

J. Ironside, 1998 .

Nodule Formation and Desmoplasia in Medulloblastomas—Defining the Nodular/Desmoplastic Variant and Its Biological Behavior

Roger E. Taylor, D. Ellison, J. Pears, 2007, Brain pathology.

Primary melanoma of the urinary bladder presenting with intracerebral metastases.

J. Royds, J. Ironside, W. Timperley, 1985, British journal of urology.

BSE and vCJD cause disturbance to uric acid levels

David R. Brown, J. Ironside, A. Green, 2004, Experimental Neurology.

Best Practice No 172 Pituitary gland pathology

J. Ironside, 2003 .

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study.

P D Griffiths, D Frappaz, P. Griffiths, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

Sonja W. Scholz, W. M. van der Flier, Till F. M. Andlauer, 2019, Acta Neuropathologica.

Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource

James W Ironside, Olaf Ansorge, Patrick F Chinnery, 2017, Genome research.

A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann–Sträussler–Scheinker disease phenotype: comparison with similar cases from the literature

F. Baas, P. Wesseling, J. Meulstee, 2010, Acta Neuropathologica.

Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.

D. Machin, D. Ellison, R. Grundy, 2010, European journal of cancer.

Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.

D. Tait, D. Ellison, R. Gilbertson, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects.

P. Simmonds, A. Busuttil, J. Bell, 1993, The Journal of infectious diseases.

Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.

D. Ellison, J. Ironside, B. Pizer, 2005, European journal of cancer.

Extra-Skeletal Ewing's sarcoma of the nasal fossa

J. Ironside, S. Lane, 1990, The Journal of Laryngology & Otology.

Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial

A. Gregor, I. Whittle, J. Ironside, 1998, Journal of neurology, neurosurgery, and psychiatry.

The accuracy of meningioma grading: a 10‐year retrospective audit

I. Whittle, J. Ironside, S. Erridge, 2005, Neuropathology and applied neurobiology.

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood ( 16 years ) low grade glioma e A final report

K. Skullerud, T. Egeland, D. Machin, 2017 .

A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702).

Jo-Fen Liu, D. Ellison, J. Ironside, 2010, Neuro-oncology.

Thomas Wisniewski, Radoslav Matej, Colin Smith, 2015, Acta Neuropathologica.

Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium

Andrew King, Isidro Ferrer, Nikolaos Kavantzas, 2009, Acta Neuropathologica.

Bilateral non-contiguous atypical papillary glioneuronal tumor: case report.

J. Harney, J. Ironside, S. Mckinstry, 2012, Clinical neuropathology.

Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies

M. Esiri, F. Baig, L. Parkkinen, 2016, Annals of clinical and translational neurology.

Serpin Signatures in Prion and Alzheimer’s Diseases

F. Tagliavini, G. Legname, J. Ironside, 2022, Molecular Neurobiology.

Hemoglobin mRNA Changes in the Frontal Cortex of Patients with Neurodegenerative Diseases

F. Tagliavini, G. Legname, I. Ferrer, 2018, Front. Neurosci..

Differential overexpression of SERPINA3 in human prion diseases

I. Ferrer, F. Tagliavini, G. Legname, 2017, Scientific Reports.

The galactocoele: a light‐ and electronmicroscopic study

J. Ironside, W. Guthrie, 1985, Histopathology.

Natasja M. KliouevaMarleen C. RademakerDavid T. Dexter • Safa Al-SarrajDanielle SeilheanNathalie StreichenbergerPeer Schmitz • Jeanne E. BellJames W. IronsideThomas ArzbergerInge Huitinga

S. Al-Sarraj, T. Arzberger, D. Dexter, 2015 .

BrainNet Europe’s Code of Conduct for brain banking

S. Al-Sarraj, T. Arzberger, J. Bell, 2015, Journal of Neural Transmission.

Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease

C. Soto, P. Schulz, F. Tagliavini, 2016, Science Translational Medicine.

Complement activation in human prion disease

H. Budka, P. Gasque, J. Ironside, 2004, Neurobiology of Disease.

Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy

J. Collinge, A. Hill, J. Ironside, 1997, The Lancet.

Prion diseases.

J. Ironside, M. Head, D. Ritchie, 2017, Handbook of clinical neurology.

Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates

J. Attems, J. Hedreen, D. Mann, 2020, Acta Neuropathologica.

Tetracyclines affect prion infectivity

G. Forloni, F. Tagliavini, M. Salmona, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Diagnostic pathology of nervous system tumours

J. Ironside, 2002 .

Neuronal apoptosis in Creutzfeldt-Jakob disease.

J. Ironside, H. Adle-Biassette, F. Chrétien, 1999, Journal of neuropathology and experimental neurology.

Convalescent plasma for administration of passive antibodies against viral agents

P. Mannucci, J. Ironside, G. Di Minno, 2020, Haematologica.

Use of 14–3–3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease

J. Ironside, A. Green, E. Thompson, 2001, Journal of neurology, neurosurgery, and psychiatry.

Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases.

James W Ironside, Sarah Cooper, J. Ironside, 2003, AJNR. American journal of neuroradiology.

Neuropathology and molecular biology of iatrogenic Creutzfeldt-Jakob disease in UK human growth hormone recipients

J. Ironside, 2017 .

Diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

S. DeArmond, H. Kretzschmar, J. Ironside, 1996, Archives of neurology.

Immunolocalisation of cytokeratins in the normal and neoplastic human pituitary gland.

J. Royds, J. Ironside, W. Timperley, 1987, Journal of neurology, neurosurgery, and psychiatry.

Diagnosis and pathogenesis of gliomas

J. Ironside, Colin Smith, 2007 .

Comparative genomic hybridization and pathological findings in atypical teratoid/rhabdoid tumour of the central nervous system

J. Royds, S. Wharton, W. Wallace, 2003, Neuropathology and applied neurobiology.

Endocrine Mucin-Producing Sweat Gland Carcinoma: Report of Two Cases of an Under-Recognized Malignant Neoplasm and Review of the Literature

J. Ironside, C. Dhaliwal, A. Biswas, 2013, The American Journal of dermatopathology.

An immunohistochemical study of glial and neuronal markers in primary neoplasms of the central nervous system

D. Graham, J. Royds, J. Ironside, 2004, Acta Neuropathologica.

Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains

J. Attems, C. Morris, C. Troakes, 2017, Acta neuropathologica communications.

Changing a single amino acid in the N‐terminus of murine PrP alters TSE incubation time across three species barriers

D. Melton, J. Ironside, J. Manson, 2001, The EMBO journal.

A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy

I. Mcconnell, D. Melton, J. Hope, 1999, The EMBO journal.

Apoptosis in human primary brain tumours.

I. Whittle, S. Wharton, J. Ironside, 1998, British journal of neurosurgery.

Chordoma masquerading as a nerve root tumour -- a clinical lesson.

J. Ironside, P. Brennan, M. O. Fitzpatrick, 2009, The British journal of radiology.

PRNP contains both intronic and upstream regulatory regions that may influence susceptibility to Creutzfeldt-Jakob Disease.

J. Ironside, J. Manson, R. Will, 2002, Gene.

Expression of Excitatory Amino Acid Transporter‐1 (EAAT‐1) in Brain Macrophages and Microglia of Patients with Prion Diseases

D. Dormont, E. Uro-Coste, J. Ironside, 2004, Journal of neuropathology and experimental neurology.

Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt–Jakob disease

J. Ironside, M. Bishop, J. Manson, 2013, Brain : a journal of neurology.

Variably protease‐sensitive prionopathy mimicking frontotemporal dementia

C. Kipps, J. Ironside, I. Bodi, 2019, Neuropathology : official journal of the Japanese Society of Neuropathology.

Variant CJD

J. Ironside, J. Manson, R. Will, 2014, Journal of the Neurological Sciences.

A case of variably protease-sensitive prionopathy treated with doxycyclin

S. Weis, H. Budka, J. Trenkler, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

The prion protein protease sensitivity, stability and seeding activity in variably protease sensitive prionopathy brain tissue suggests molecular overlaps with sporadic Creutzfeldt-Jakob disease

J. Ironside, M. Head, M. Barria, 2014, Acta neuropathologica communications.

Human prion diseases and the risk of their transmission during anatomical dissection

J. Ironside, N. Mabbott, P. Piccardo, 2014, Clinical anatomy.

Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?

S. Weis, H. Budka, R. Katzenschlager, 2013, Acta neuropathologica communications.

The contribution of different prion protein types and host polymorphisms to clinicopathological variations in Creutzfeldt–Jakob disease

J. Ironside, M. Head, 2012, Reviews in medical virology.

Correlation of Polydispersed Prion Protein and Characteristic Pathology in the Thalamus in Variant Creutzfeldt‐Jakob Disease: Implication of Small Oligomeric Species

J. Ironside, M. Head, A. Gröner, 2011, Brain pathology.

31st Advanced Clinical Neurology Course, Edinburgh 2009: progressive cognitive impairment, behavioural change and upper motor neuron signs in a 57-year-old woman

A. Zeman, J. Ironside, S. Pal, 2011, Practical Neurology.

Variably protease-sensitive prionopathy in a PRNP codon 129 heterozygous UK patient with co-existing tau, α synuclein and Aβ pathology

J. Ironside, M. Head, S. Lowrie, 2010, Acta Neuropathologica.

Genetic influence on the structural variations of the abnormal prion protein.

B. Ghetti, H. Kretzschmar, P. Brown, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions

Armin Giese, James Ironside, Sabina Capellari, 2016, Journal of Virology.

The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients

Roger A. Moore, J. Ironside, S. Priola, 2016, PLoS pathogens.

The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients

Roger A. Moore, J. Ironside, S. Priola, 2016, PLoS pathogens.

Prion protein heterogeneity in sporadic but not variant Creutzfeldt–Jakob disease: U.K. cases 1991–2002

J. Ironside, M. Bishop, R. Will, 2004, Annals of neurology.

Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease.

J. Ironside, M. Head, 2004, Current topics in microbiology and immunology.

Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors.

S. Mead, J. Collinge, S. Joiner, 2011, Brain : a journal of neurology.

Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK

Rosemary J. Jackson, M. Keogh, P. Chinnery, 2017, Acta Neuropathologica.

Immunolocalization of cathepsin D in the human central nervous system and central nervous system neoplasms

J. Ironside, W. Reid, D. Robson, 1990, Neuropathology and applied neurobiology.

Variably protease-sensitive prionopathy

J. Ironside, M. Head, 2014 .

Heparin enhances the cell-protein misfolding cyclic amplification efficiency of variant Creutzfeldt–Jakob disease

Miyuki Yamamoto, T. Yokoyama, J. Ironside, 2011, Neuroscience Letters.

14 Neuropathology of Prion Diseases

S. DeArmond, J. Ironside, 1999 .

A prion protein epitope selective for the pathologically misfolded conformation

S. Laboissiere, A. Chakrabartty, H. Ledebur, 2003, Nature Medicine.

Comparative Study of Prions in Iatrogenic and Sporadic Creutzfeldt-Jakob Disease

E. Uro-Coste, P. Brown, J. Ironside, 2014, Journal of clinical & cellular immunology.

Prion diseases in man

J. Ironside, 1998, The Journal of pathology.

Neuropathology of variant Creutzfeldt-Jakob disease.

J. Ironside, L. McCardle, M. Head, 2002, Acta neurobiologiae experimentalis.

The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease

James W Ironside, Simon Cousens, D. Hadley, 2000, The Lancet.

Diagnosis of new variant Creutzfeldt‐Jakob disease

S. Cousens, J. Ironside, A. Green, 2000, Annals of neurology.

Investigation of prion diseases.

J. Ironside, D. Seilhean, M. Head, 2001, Current topics in pathology. Ergebnisse der Pathologie.

Brain biopsy and patients with atypical presentations of sporadic Creutzfeldt- Jakob disease

I. Whittle, J. Ironside, R. Will, 1997, Journal of Neurology Neurosurgery & Psychiatry.

A case of Creutzfeldt-Jakob disease presenting with cortical deafness.

I. Bone, R. de Silva, J. Ironside, 1994, Journal of neurology, neurosurgery, and psychiatry.

Biology and neuropathology of prion diseases.

J. Ironside, M. Head, 2008, Handbook of clinical neurology.

Inherited multiple meningiomas: a clinical, pathological and cytogenetic study of an affected family.

J. Ironside, E. Maltby, R. Battersby, 1986, Journal of neurology, neurosurgery, and psychiatry.

Spinal subependymoma surgery: do no harm. Little may be more!

J. Ironside, A. Demetriades, H. Soleiman, 2019, Neurosurgical Review.

Fourth ventricle ependymoma in father and son

J. Ironside, S. Erridge, L. Myles, 2008, British journal of neurosurgery.

Transmission of fatal familial insomnia to laboratory animals

P. Lantos, J. Collinge, J. Ironside, 1995, The Lancet.

Neuropathological and neurophysiological effects of interstitial white matter autologous and non-autologous protein containing solutions: Further evidence for a glioma derived permeability factor

I. Piper, J. Miller, I. Whittle, 2005, Acta Neurochirurgica.

Protection of personnel and environment against Creutzfeldt-Jakob disease in pathology laboratories.

J. Ironside, L. McCardle, N. Kopp, 1999, Clinical and experimental pathology.

High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy

D. Graham, S. Love, H. Vinters, 1997, Annals of neurology.

Human prion diseases.

J. Ironside, 2018, Journal of neural transmission. Supplementum.

Temozolomide i n M alignant G liomas o f C hildhood: A U nited Kingdom C hildren's C ancer S tudy G roup a nd F rench S ociety for P ediatric O ncology I ntergroup S tudy

D. Frappaz, A. Jouvet, G. Vassal, 2002 .

The choroid plexus carcinomas of childhood: histopathology, immunocytochemistry and clinicopathological correlations

M. Newbould, A. Kelsey, J. Ironside, 1995, Histopathology.

Atypical cytomegalovirus retinitis: a clinicopathological correlation.

J. Ironside, B. Dhillon, S. Burns, 1994, The British journal of ophthalmology.

Neuronal Apoptosis in Fatal Familial Insomnia

H. Budka, J. Ironside, F. Chrétien, 1998, Brain pathology.

Inherited Creutzfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene.

R. Lathe, S. Sawcer, O. Windl, 1995, Journal of neurology, neurosurgery, and psychiatry.

Pathology of tumours of the central nervous system

J. Ironside, A. Ironside, 2009 .

Update on central nervous system cytopathology. II. Brain smear technique.

J. Ironside, 1994, Journal of clinical pathology.

childhood . derived growth hormone therapy in Creutzfeldt-Jakob disease after pituitary Neurosurgery in a patient with

J. Ironside, S. Shalet, S. Holmes, 2003 .

Prevalence in Britain of abnormal prion protein in human appendices before and after exposure to the cattle BSE epizootic

J. Linehan, S. Brandner, M. Simmons, 2020, Acta Neuropathologica.

Genotype-dependent Molecular Evolution of Sheep Bovine Spongiform Encephalopathy (BSE) Prions in Vitro Affects Their Zoonotic Potential*

J. Ironside, M. Head, M. Barria, 2014, The Journal of Biological Chemistry.

Human stem cell–derived astrocytes replicate human prions in a PRNP genotype–dependent manner

S. Chandran, Robert Krencik, E. Ullian, 2017, The Journal of experimental medicine.

Progressive aphasia with rapidly progressive dementia in a 49 year old woman

J. Hodges, C. Warlow, J. Ironside, 1999, Journal of neurology, neurosurgery, and psychiatry.

COMPLETE OCCLUSION OF THE ANTERIOR CAPSULAR OPENING BY FIBROCELLULAR MEMBRANE ASSOICATED WITH RETAINED SILICONE OIL: A Clinicopathologic Correlation

J. Ironside, N. Patton, T. Aslam, 2004, Retina.

An unusual case of Wilson's disease.

J. Ironside, D. Triger, J. W. Madden, 1985, The Quarterly journal of medicine.

Neurodegeneration: The molecular pathology of dementia and movement disorders

J. Ironside, M. Head, R. Knight, 2003 .

Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans.

S. Prusiner, S. DeArmond, J. Ironside, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Molecular Model of Prion Transmission to Humans

C. Prowse, J. Ironside, J. Manson, 2009, Emerging infectious diseases.

Tubular apocrine adenoma—an unusual eyelid tumour

J. Ironside, B. Dhillon, C. Smith, 2005, Eye.

Chapter 23 – Prion Diseases

P. Liberski, J. Ironside, 2015 .

BSE transmission to macaques

J. Hauw, D. Dormont, J. Ironside, 1996, Nature.

The Brain Smear, a Rapid Affordable Intraoperative Diagnostic Technique for Brain Tumours Appropriate for Africa

J. Ironside, B. Olasode, 2004, Tropical doctor.

Sodium and chloride channelopathies with myositis: Coincidence or connection?

J. Holton, G. Ambler, J. Ironside, 2011, Muscle & nerve.

human pituitary gland . in the normal and neoplastic Immunolocalisation of cytokeratins

J. Royds, J. Ironside, W. Timperley, 2022 .

Primary lymphoma of central nervous system in immunocompetent patients in south-east Scotland

I. Whittle, J. Ironside, D. Signorini, 1996, The Lancet.

Missed Diagnosis Whipple ' s disease with cerebral involvement

J. Ironside, P. Hamal, D. Robson, 2008 .

Prion Diseases: Transmissible Spongiform Encephalopathies

J. Ironside, 2015, Red Book Atlas of Pediatric Infectious Diseases.

Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides

T. Wisniewski, C. Soto, F. Tagliavini, 2000, The Lancet.

Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition

B. Costall, R. Naylor, N. Barnes, 1990, Brain Research.

Angiotensin II Inhibits Cortical Cholinergic Function: Implications for Cognition

B. Costall, R. Naylor, N. Barnes, 1990, Journal of cardiovascular pharmacology.

Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment.

T. Hortobágyi, J. Attems, D. Mann, 2016, Brain : a journal of neurology.

The Apolipoprotein E ∈2 Allele and the Pathological Features in Cerebral Amyloid Angiopathy-related Hemorrhage

D. Graham, D. Mann, S. Love, 1999 .

Malignant peripheral nerve sheath tumour arising in a schwannoma

J. Ironside, D. Robson, 1990, Histopathology.

FFI Cases from the United Kingdom

J. Bell, J. Ironside, R. Will, 1998, Brain pathology.

Anti-hu paraneoplastic syndrome presenting as bilateral sixth cranial nerve palsies.

J. Ironside, R. Mcfadzean, Tarek Hammam, 2005, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

The balance of care.

J. Ironside, M. McMahon, B. Barron, 1998, Studies in health technology and informatics.

Molecular assessment of the potential transmissibilities of BSE and scrapie to humans

P. Lansbury, G. J. Raymond, M. Smits, 1997, Nature.

Pre‐menopausal cytomegalovirus oophoritis

J. Ironside, D. Williams, P. Connor, 1990, Histopathology.

Primary Cerebellopontine Angle Melanocytoma: Review

J. Ironside, S. Eljamel, I. Phang, 2012, Journal of Neurosurgical Surgery Reports.

Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt– Jakob disease: Implications for human health

J. Hauw, D. Dormont, J. Ironside, 2001, Proceedings of the National Academy of Sciences of the United States of America.

The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.

D. Graham, D. Mann, S. Love, 1999, Journal of neuropathology and experimental neurology.

Liver and pituitary abnormalities in Hallervorden-Spatz disease.

J. Ironside, D. Williams, 1989, Journal of neurology, neurosurgery, and psychiatry.

Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood.

J. Ironside, S. Shalet, S. Holmes, 1996, Journal of neurology, neurosurgery, and psychiatry.

Sporadic Creutzfeldt-Jakob Disease in 2 Plasma Product Recipients, United Kingdom

A. Molesworth, J. Ironside, R. Will, 2017, Emerging infectious diseases.

Comparison of the in vitro seeding activity of UK iatrogenic and sporadic Creutzfeldt-Jakob disease subtypes by real time quaking induced conversion

J. Ironside, M. Head, A. Peden, 2016 .

Minimise transmission risk of CJD and vCJD in healthcare settings. Report on the Prevention of CJD and vCJD by Advisory Committee on Dangerous Pathogens' Transmission Spongiform Encephalopathy (ACDP TSE) Subgroup.

D. Jeffries, R. Cumming, A. Fraise, 2015 .

UNRAVELLING THE MYSTERIES OF SPORADIC CJD

J. Ironside, M. Head, G. Mackay, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study

James W Ironside, K. Connolly, J. Ironside, 2006, BMJ : British Medical Journal.

An update on variant CJD (vCJD), secondary transmission and prevalence

A. Ghani, J. Ironside, R. Will, 2006 .

Mikulicz syndrome and disease: 2 case reports highlighting the difference

J. Ironside, J. F. Cullen, Z. Butt, 1993, Acta ophthalmologica.

Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study

John Seibyl, Ana M Catafau, Henryk Barthel, 2016, The Journal of Nuclear Medicine.

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection

W. Klunk, C. Mathis, Colin Smith, 2016, Acta neuropathologica communications.

Cerebellar Amyloid-β Plaques: How Frequent Are They, and Do They Influence 18F-Florbetaben SUV Ratios?

Osama Sabri, Ana M Catafau, Bernardino Ghetti, 2016, The Journal of Nuclear Medicine.

Ganciclovir implant: Clinicopathological study

J. Ironside, B. Dhillon, N. Al-Yousuf, 2000, Eye.

Bovine spongiform encephalopathy and risk to health.

J. Bell, J. Ironside, R. Will, 1992, BMJ.

Influence of Intracerebral Hemorrhage Location on Incidence, Characteristics, and Outcome: Population-Based Study

C. Sudlow, P. Sandercock, G. Mead, 2015, Stroke.

Absence of cystatin C mutation in sporadic cerebral amyloid angiopathy–related hemorrhage

S. Love, J. Ironside, D. Graham, 2000, Neurology.

Novel Antibody-Lectin Enzyme-Linked Immunosorbent Assay That Distinguishes Prion Proteins in Sporadic and Variant Cases of Creutzfeldt-Jakob Disease

M. Sy, J. Ironside, B. Wong, 2005, Journal of Clinical Microbiology.

TOXICITY OF CYCLSPORIN METABOLITES

A. Davenport, J. Ironside, A. Davison, 1988, The Lancet.

Toxicity of cyclosporin metabolites.

A. Davenport, J. Ironside, A. Davison, 1988, Lancet.

Multicentre phase 3 trial on florbetaben for beta-amyloid brain PET in Alzheimer's disease

M. Sabbagh, J. Seibyl, B. Ghetti, 2012, Alzheimer's & Dementia.

Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases

M. Esiri, J. Ironside, J. M. Carter, 2000, Neuropathology and applied neurobiology.

Nitric oxide synthase is expressed in experimental malignant glioma and influences tumour blood flow

I. Whittle, J. Ironside, F. Collins, 2005, Acta Neurochirurgica.

Global democratic consensus on neuropathological disease criteria

D. Graham, B. Scheithauer, J. Trojanowski, 2002, The Lancet Neurology.

Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue

B. Costall, R. Naylor, N. Barnes, 1991, Neuropharmacology.

The need to unify neuropathological assessments of vascular alterations in the ageing brain Multicentre survey by the BrainNet Europe consortium

K. Jellinger, T. Hortobágyi, J. Attems, 2012, Experimental Gerontology.

Florid plaques and new variant Creutzfeldt-Jakob disease

J. Bell, J. Ironside, J. Bell, 1997, The Lancet.

Registration quality and descriptive epidemiology of childhood brain tumours in Scotland 1975-90.

E. Harkness, J. Ironside, P. McKinney, 1994, British Journal of Cancer.

Efficient propagation of variant Creutzfeldt‐Jakob disease prion protein using the cell‐protein misfolding cyclic amplification technique with samples containing plasma and heparin

T. Yokoyama, J. Ironside, T. Kitamoto, 2016, Transfusion.

Creutzfeldt–Jakob disease and the eye

J. Ironside, M. Head, 2008 .

Application of Atomic Dielectric Resonance Spectroscopy for the screening of blood samples from patients with clinical variant and sporadic CJD

G. C. Stove, M. Turner, J. Ironside, 2007, Journal of Translational Medicine.

Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

J. Ironside, D. Ritchie, A. Peden, 2006, Folia neuropathologica.

Variation in concentration of prion protein in the peripheral blood of patients with variant and sporadic Creutzfeldt‐Jakob disease detected by dissociation enhanced lanthanide fluoroimmunoassay and flow cytometry

M. Turner, J. Ironside, G. Barclay, 2005, Transfusion.

Retrospective study of prion-protein accumulation in tonsil and appendix tissues

A. Ghani, J. Ironside, L. McCardle, 2000, The Lancet.

Human immunodeficiency virus and the brain

P. Simmonds, A. Busuttil, J. Bell, 1993 .

High frequency of apolipoprotein E ε2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy

D. Graham, S. Love, H. Vinters, 1996 .

Behavioural disturbance and visual hallucinations in a 78 year old man

C. Warlow, J. Ironside, G. Lennox, 1998, Journal of neurology, neurosurgery, and psychiatry.

A quantitative and qualitative analysis of prion protein immunohistochemical staining in Creutzfeldt-Jakob disease using four anti prion protein antibodies.

J. Ironside, S. MacDonald, K. Sutherland, 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

Pre‐symptomatic detection of prions by cyclic amplification of protein misfolding

J. Castilla, P. Saá, C. Soto, 2005, FEBS letters.

Effective implementation of the Human Tissue Act

J. Ironside, 2006, The Lancet.

An intramedullary vascular malformation mimicking intrinsic spinal cord tumour

K. Kurian, J. Ironside, I. Whittle, 2006, British journal of neurosurgery.

Molecular pathology in neurodegenerative diseases.

J. Ironside, A. Peden, 2012, Current drug targets.

The application of in vitro cell-free conversion systems to human prion diseases

J. Ironside, M. Head, A. Peden, 2010, Acta Neuropathologica.

High-Depth PRNP Sequencing in Brains With Sporadic Creutzfeldt-Jakob Disease

M. Keogh, P. Chinnery, J. Ironside, 2023, Neurology: Genetics.

CLINICAL NEUROSCIENCE: Amyloid beta-protein length and cerebral amyloid angiopathy-related haemorrhage

D. Graham, D. Mann, S. Love, 2000 .

Differential protein profiling as a potential multi-marker approach for TSE diagnosis

M. Watson, J. Ironside, M. Head, 2009, BMC infectious diseases.

Sporadic Creutzfeldt-Jakob disease: discrete subtypes or a spectrum of disease?

J. Ironside, M. Head, 2009, Brain : a journal of neurology.

Erratum to: Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains

J. Attems, C. Morris, C. Troakes, 2017, Acta neuropathologica communications.

New lexicon and criteria for the diagnosis of Alzheimer's disease

P. Falkai, B. Winblad, C. Duyckaerts, 2011, The Lancet Neurology.

J. Ironside, R. Will, M. Zeidler, 2011 .

Variant Creutzfeldt-Jakob disease: an update.

J. Ironside, 2012, Folia neuropathologica.

Oppenheimer's Diagnostic Neuropathology: A Practical Manual

J. Ironside, 1997 .

[Consensus report: tissue handling in suspected Creutzfeldt-Jakob disease and other spongiform encephalopathies (prion diseases) in the human. European Union Biomed-1 Concerted Action].

W. Schlote, P. Lantos, A. Aguzzi, 1996, Der Pathologe.

High frequency of apolipoprotein E epsilon 2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy.

D. Graham, S. Love, H. Vinters, 1996, Annals of neurology.

Reply to “Striking PrPsc heterogeneity in inherited prion diseases with the D178N mutation”.

J. Ironside, M. Head, 2004 .

Accumulation of prion protein in tonsil and appendix: review of tissue samples

A. Ghani, J. Ironside, L. McCardle, 2002, BMJ : British Medical Journal.

Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt–Jakob disease

C. Wiley, J. Ironside, L. McCardle, 2004, Journal of Clinical Pathology.

NEUROPATHOLOGY OF NEURODEGENERATIVE DISEASES: A PRACTICAL GUIDE

J. Ironside, 2015 .

N‐glycosylation and expression in human tissues of the orphan GPR61 receptor

A. Cooper, N. Barnes, J. Ironside, 2017, FEBS open bio.

Cerebral Ischemia: Molecular and Cellular Pathophysiology.

J. Ironside, J. W. Ironside, 2000 .

Infective dementias.

J. Bell, J. Ironside, 2007, Panminerva medica.

Retrospective Neuropathological Review of Prion Disease in UK Haemophilic Patients

M. Esiri, P. Giangrande, Christine A. Lee, 1998, Thrombosis and Haemostasis.

A new variant of Creutzfeldt-Jakob disease in the UK

A. Hofman, A. Alpérovitch, S. Cousens, 1996, The Lancet.

Edinburgh Research Explorer Differential overexpression of SERPINA3 in human prion diseases

I. Ferrer, F. Tagliavini, G. Legname, 2022 .

Cerebral metastasis from a malignant mixed Müllerian tumour of the uterus

J. Ironside, J. Iqbal, 1993, Histopathology.

Greenfield's Neuropathology - Two Volume Set

H. Budka, S. Love, J. Ironside, 2018 .

Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples

J Collinge, P. Lantos, M. Rossor, 1999, The Lancet.

Autoimmune Hypothyroidism Coexisting with a Pituitary Adenoma Secreting Thyroid-Stimulating Hormone, Prolactin and α-Subunit

S. Atkin, G. Beckett, J. Ironside, 2001, Annals of clinical biochemistry.

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.

J. Bell, J. Ironside, M. Head, 2004, Lancet.

Variant Creutzfeldt–Jakob disease and its transmission by blood

J. Ironside, J. Ironside, M. Head, 2003, Journal of thrombosis and haemostasis : JTH.

Edinburgh Research Explorer Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains

J. Attems, C. Morris, C. Troakes, 2022 .

Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study

J. Ironside, J. W. Ironside, 2006, BMJ : British Medical Journal.

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.

J. Bell, J. Ironside, M. Head, 2004, Lancet.

RNA integrity in post mortem human variant Creutzfeldt–Jakob disease (vCJD) and control brain tissue

R. Walker, J. Ironside, J. Fazakerley, 2011, Neuropathology and applied neurobiology.

Prion diseases in man

J. Ironside, 1998, The Journal of pathology.

In vitro amplification and detection of variant Creutzfeldt–Jakob disease PrPSc

C. Prowse, J. Ironside, J. Manson, 2007, The Journal of pathology.

Pathological diagnosis of variant Creutzfeldt‐Jakob disease

J. Ironside, A. Horsburgh, J. Ironside, 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

The ‘high‐risk’ neuropathological autopsy in AIDS and Creutzfeldt‐Jakob disease: principles and practice

J. Bell, J. Ironside, J. Ironside, 1996, Neuropathology and applied neurobiology.

Review: Creutzfeldt‐Jakob Disease

J. Ironside, J. Ironside, 1996, Brain pathology.

the CSF of patients

M. Esiri, F. Baig, L. Parkkinen, 2016 .

Variant Creutzfeldt–Jakob disease: risk of transmission by blood transfusion and blood therapies

J. Ironside, J. Ironside, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Ultrastructural study of florid plaques in variant Creutzfeldt–Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt–Jakob disease and Gerstmann–Sträussler–Scheinker disease

H. Budka, P. Liberski, J. Ironside, 2009, Neuropathology and Applied Neurobiology.

Variant Creutzfeldt–Jakob disease: risk of transmission by blood and blood products

J. Ironside, J. Ironside, M. Head, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

K. Skullerud, T. Egeland, D. Machin, 2017, European journal of cancer.

Dataset for tumours of the central nervous system, including the pituitary gland (4th edition)

T. Jacques, S. Brandner, S. Wharton, 2016 .

Glioma cells transduced with selection transgenes may not form gliomas in vivo and can also inhibit glioma formation by admixed wild glioma cell lines.

I. Whittle, J. Ironside, M. Li, 1997, Acta neurochirurgica. Supplement.

Version final SOURCE ( OR PART OF THE FOLLOWING SOURCE ) : Type article Title The first case of protease-sensitive prionopathy ( PSPr ) in The Netherlands : a patient with an unusual GSS-like clinical phenotype

F. Baas, M. A.J., W. A. Gool, 2022 .

A case of protease sensitive prionopathy in a patient in the UK

J. Ironside, J. Ironside, M. Zeidler, 2009, Neuropathology and applied neurobiology.

Referral pattern and management of patients with malignant brain tumours in south east Scotland.

A. Gregor, J. Ironside, D. Collie, 1996, Health bulletin.

Tumors of the Peripheral Nervous System.

J. Ironside, 2000 .

Predicting susceptibility and incubation time of human-to-human transmission of vCJD

J. Ironside, M. Bishop, J. Manson, 2005, The Lancet Neurology.

Iatrogenic Creutzfeldt – Jakob disease : investigating human prion transmission across genotypic barriers using human tissue ‐ based and molecular approaches

J. Ironside, M. Head, D. Ritchie, 2016 .

Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia

S. Love, S. Cousens, J. Ironside, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Greenfield's Neuropathology (Ninth edition)

B. Ghetti, J. Ironside, M. Head, 2015 .

Acquired immunodeficiency syndrome-related primary central nervous system lymphoma.

J. Ironside, B. Dhillon, H. Maclean, 1994, A M A Archives of Ophthalmology.

RNA integrity in post mortem human variant Creutzfeldt–Jakob disease (vCJD) and control brain tissue

R. Walker, J. Ironside, J. Fazakerley, 2011, Neuropathology and applied neurobiology.

LYMPHOMATOID GRANULOMATOSIS WITH CEREBRAL INVOLVEMENT

J. Ironside, W. Timperley, J. Martin, 1984, Neuropathology and applied neurobiology.

Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank

Colin Smith, R. Walker, J. Bell, 2007, The Journal of pathology.

Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource

J. Attems, C. Troakes, S. Rollinson, 2017, Genome research.

P. Liberski, J. Ironside, B. Sikorska, 2009, Neuropathology and applied neurobiology.

Neuropathology of Human Prion Diseases.

J. Ironside, D. Ritchie, 2017, Progress in molecular biology and translational science.

Biological Effects and Use of PrPSc- and PrP-Specific Antibodies Generated by Immunization with Purified Full-Length Native Mouse Prions

L. Stitz, C. Korth, J. Ironside, 2011, Journal of Virology.

Sporadic Creutzfeldt-Jakob disease

J. Ironside, P. Gambetti, Piero Parchi, 2003 .

Variant CJD

J. Ironside, J. Manson, R. Will, 2014, Prion.

K. Jellinger, T. Hortobágyi, T. Montine, 2015, Acta Neuropathologica.

Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study.

J. Ironside, R. Battersby, W. Timperley, 1986, Journal of clinical pathology.

Quantitative variations in the pathology of 11 cases of variant Creutzfeldt-Jakob disease (vCJD).

P. Lantos, N. Cairns, J. Ironside, 2002, Pathophysiology : the official journal of the International Society for Pathophysiology.

Characterization of Variant Creutzfeldt-Jakob Disease Prions in Prion Protein-humanized Mice Carrying Distinct Codon 129 Genotypes*

S. Mohri, J. Ironside, T. Kitamoto, 2013, The Journal of Biological Chemistry.

Variant Creutzfeldt–Jakob disease

J. Ironside, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Variant Creutzfeldt–Jakob Disease

J. Ironside, D. Ritchie, 2009 .

Neuropathology of variant Creutzfeldt-Jakob disease.

J. Ironside, 2002, Comptes rendus biologies.

An experimental study to evaluate the accuracy of diencephalic and pallidal target localization using the Brown-Roberts-Wells stereotactic system and unreformatted axial GE8800 CT scanning.

I. Whittle, J. Ironside, M. O'sullivan, 1994, British journal of neurosurgery.

Progesterone receptors in meningiomas: morphometric assessment of vascularity and cellularity on near facsimile cryostat sections.

J. Ironside, R. Battersby, W. Timperley, 1986, Journal of clinical pathology.

Biochemical typing of scrapie strains - Reply

J. Collinge, A. Hill, J. Ironside, 1997 .

Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey

J. Linehan, S. Brandner, M. Simmons, 2013, BMJ.

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection

W. Klunk, C. Mathis, C. Buckley, 2016, Acta Neuropathologica Communications.

Spontaneous spongiform encephalopathy in a monkey

R. Ridley, H. Baker, J. Ironside, 1996, The Lancet.

Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies

P. Liberski, W. Papierz, M. Zakrzewska, 2010, Journal of Neuro-Oncology.

Prions and the Oral Cavity

C. Scully, J. Ironside, R. Will, 2003, Journal of dental research.

Inter‐Laboratory Assessment of PrPSc Typing in Creutzfeldt–Jakob Disease: A Western Blot Study within the NeuroPrion Consortium

J. Hauw, H. Budka, H. Kretzschmar, 2009, Brain pathology.

New‐variant Creutzfeldt‐Jakob disease

J. Ironside, 1998 .

Beyond PrP res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.

J. Hauw, J. Langeveld, E. Uro-Coste, 2008, PLoS pathogens.

Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.

J. Ironside, S. Priola, M. Head, 2014, The American journal of pathology.

36. Variant Creutzfeldt–Jakob Disease

J. Ironside, R. Will, M. Head, 2011 .

Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium

I. Ferrer, S. Al-Sarraj, I. Alafuzoff, 2009, Acta Neuropathologica.

Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes.

J. Ironside, J. Manson, P. D. De Sousa, 2014, The American journal of pathology.